The Low DoseThe GLP-1 price desk
Briefing

Fifty 410 vs Noom Med

$133/mo against $149/mo for tirzepatide. Which is worth it, and for whom.

Illustration of two objects on a balance scale

Updated 2026-09-18

Both sell tirzepatide. Fifty 410 costs $133 a month and Noom Med costs $149, a difference of $16 a month or about $192 a year. The desk reads it as follows.

Fifty 410 is prepaid blocks with no subscription. Noom Med is behaviour change alongside medication. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Fifty 410 advertises $133 and bills $133; Noom Med advertises $149 and bills $149. Both gaps are the same size, so the advertised comparison happens to hold.

Side by side

Fifty 410Noom
Advertised$133$149
Billed$133$149
Gapnonenone
Per year, billed$1,596$1,788

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

2 differences on the record. The others match.

Fifty 410Noom
Month-to-month without prepaying a blockNoYes
Medication included in the monthly priceYesNo

What each puts on the record: Fifty 410

  • Provider consultation and free 1-2 day shipping included in the price.
  • States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.

Where it wins: Genuinely no subscription — you buy a block and nothing recurs. Watch for: The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.

What each puts on the record: Noom Med

    Where it wins: The coaching is the actual product here and it is well built. Watch for: A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.

    In each one’s favour

    Fifty 410.

    • Genuinely no subscription — you buy a block and nothing recurs.
    • Among the lowest tirzepatide rates verified.

    Noom Med.

    • The coaching is the actual product here and it is well built.
    • Medication is included in the microdose tier rather than billed separately.

    Fifty 410 scores higher overall at 4.2 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

    The desk’s call

    The board says Fifty 410. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.

    The verdict

    On the board, Fifty 410 at $133 a month is the more defensible choice on arithmetic alone. Noom Med earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Fifty 410 and Noom Med.

    How they sit against everyone else

    ProgrammeAdvertisedBilledGapVs board floor
    Coreage Rx$149$199+$50+$74/mo
    Trimi$125$125none—
    Ozari Health$125$125none—
    Fifty 410$133$133none+$8/mo

    More from the desk

    • Fifty 410 tirzepatide review

      Advertised at $133 and billed at $133 — no gap. Position 4 of 18 on our board.

    • Noom Med tirzepatide review

      Advertised at $149 and billed at $149 — no gap. Position 0 of 18 on our board.

    • How to spot a bad seller

      The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

    • The twelve-month cost

      Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

    • Cheapest right now

      Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

    Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure